Thursday - October 23, 2025
UM Miller School of Medicine: Transient Rapamycin Treatment Enables Long-Term Delivery of Anti-HIV Antibodies
October 08, 2025
MIAMI, Florida, Oct. 8 (TNSjou) -- The University of Miami Miller School of Medicine issued the following news:

* * *

Transient Rapamycin Treatment Enables Long-Term Delivery of Anti-HIV Antibodies

Summary

* Delivering broadly neutralizing antibodies (bnAbs) efficiently and sustainably to HIV patients remains a challenge.

* Dr. Ronald Desrosiers looked at transient treatment with rapamycin to enable long-term delivery of anti-HIV b . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products